×
戻る Agenda
Session 7: Overview of China
Session Chair(s)
Michael Hamrell, PhD, RAC
President
MORIAH Consultants, United States
- The Chinese regulatory environment
- Developing new drugs for Chinese approval
- Communications with CDE and CFDA